期刊文献+

非小细胞肺癌组织CD151蛋白表达临床意义探讨 被引量:13

Clinical significance of CD151 expression in non-small cell lung cancer
原文传递
导出
摘要 目的:探讨CD151在非小细胞肺癌(non-small cell lung cancer,NSCLC)组织中的表达及意义。方法:免疫组化SP法检测云南省肿瘤医院2006-01-01-2011-12-31收治的78例NSCLC和22例良性肺病变组织中CD151蛋白的表达,并结合临床资料进行分析。RT-PCR法检测正常支气管上皮细胞株BEAS-2B、肺腺癌细胞株A549、云南宣威肺癌细胞株XWLC-05和云南个旧肺鳞癌细胞株YTMLC中CD151mRNA的相对表达量。结果:CD151在NSCLC组织中表达阳性率为57.7%(45/78),高于对照组的18.2%(4/22),χ2=10.72,P=0.001。CD151蛋白表达与性别、年龄、是否吸烟、T分期、TNM分期、肿瘤细胞分化程度以及PS评分无明显相关性,P值均>0.05;与病理分型(χ2=6.312,P=0.043)和淋巴结数(χ2=7.386,P=0.007)有关。生存分析提示,CD151蛋白阳性表达预后差;Cox回归分析表明,CD151蛋白是影响NSCLC预后的独立危险因素,P=0.014。荧光定量PCR结果显示,CD151mRNA在细胞株中的表达为BEAS-2B>A549>XWLC-05>YTMLC。结论:CD151蛋白可以作为判断NSCLC预后的参考之一。CD151mRNA在细胞株A549和XWLC-05中高表达,为进一步研究肺癌高发区特殊环境作用下发病机制以及预防、治疗提供新的思路。 OBJECTIVE:To investigate the clinical significance of CD151 expression in non-small cell lung cancer. METHODS : Immunohistochemical staining of SP was applied in the specimens of 78 NSCLC and 22 benign pulmonary dis- eases to investigate the expression of CD151 protein from January ls~,2006 to December 3lth,2011 in Yunnan Province Tumor Hospital. The correlation between the expression of CD151 and clinicopathologic features of NSCLC was analyzed. RT-PCR was applied to explore the expression of CD151 mRNA in BEAS-2B, A549, Xuanwei lung adenocarcinoma cell lines XWLC-05 and Gejiu lung squamous carcinoma cell lines YTMLC. RESULTS: The positive rate of CD151 protein in specimens of NSCLC was 57.70/oo ,which was higher than 18.2% of benign pulmonary diseases (X2 =10.72,P=0. 001). Overexpression of CDJ51 protein in NSCLC was not correlated with sex, age, smoking, T-stage,TNM-stage, differentia- tion and performance status, but was correlated with histology ( X2 = 6. 312, P = 0. 043) and N-stage ( X2 = 7. 386, P = 0. 007). Kaplan-Meier survival analysis and log-rank test suggested that overexpression of CD151 protein had poor prog- nosis. Cox regression suggested CD151 protein expression was independent prognostic factor of NSCLC(P^0. 014). Real- time PCR showed the expression of CD151 mRNA was BEAS-2B〉A549〉XWLC-05〉YTMLC. CONCLUSIONS: Over- expression of CD151 protein in NSCLC is correlated with poor prognosis and it can be served as a prognostic factor of NSCLC. There is overexpression of CD151 mRNA in A549 and XWLC-05 ,which could provide new ideas for the study of pathogenesis, prevention and treatment of Iung cancer developed in special environment.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2014年第1期34-38,共5页 Chinese Journal of Cancer Prevention and Treatment
关键词 非小细胞肺 基因 CDl51 预后 细胞珠XWLC-05 细胞珠YTMLC 细胞珠A549 免疫组织化学 carcinoma,non-small cell lung genes, CD151 prognosis cell line XWLC-05 cell line YTMLC cell lineA549 ~ immunohistochemistry
  • 相关文献

参考文献13

  • 1李婷,任精华,马艳青,雷艳荣,农丽,张赟.β1-509C/T基因多态性与中国人群NSCLC遗传易感相关性的研究[J].中华肿瘤防治杂志,2012,19(6):410-414. 被引量:7
  • 2李学祥,王慜杰,高佳,韩彬彬,齐军,毛友生.肺肿瘤患者临床病理特征回顾性分析[J].中华肿瘤防治杂志,2012,19(2):130-133. 被引量:15
  • 3Huang XY,Ke AW,Shi GM,et al.Overexpression of CD151 asan adverse marker for intrahepatic cholangiocarcinoma patients[J].Cance,2010,116(23):5440-5451.
  • 4Tokuhara T,Hasegawa H,Hattori N,et al.Clinical significanceof CD151 gene expression in non-small cell lung cancer[J].ClinCancer Res,2001,7(12):4109-4114.
  • 5Ke AW,SKi GM,Zhou J,et al.Role of overexpression of CD151and/or c-Met in predicting prognosis of hepatocellulai carcinoma[J].Hepatology,2009,49(2):491-503.
  • 6Hashida H,Takabayashi A,Tokuhara T,et al.Clinical signifi-cance of transmembrane 4 super family in colon cancer[J].Br JCancer,2003,89(1):158-167.
  • 7Ang J,Lijovic M,Ashman LK,et al.CD151 protein expressionpredicts the clinical outcome of low-grade primary prostate canc-er better than histologic grading:a new prognostic indicator?[J].Cancer Epidemiol Biomarkers Prev,2004,13(11):1717-1721.
  • 8安舟,沈毅弘,周建英,李敏伟.PETA-3?CD151在非小细胞肺癌组织中的表达及其临床意义[J].浙江医学,2004,26(4):249-251. 被引量:3
  • 9Yoo SH,Lee K,Chae JY,et al.CD151 expression can predict cancerprogression in clear cell renal cell carcinoma[J].Histopathology,2011,58(2):191-197.
  • 10Voss MA,Gordon N,Maloney S,et al.Tetraspanin CD151 is anovel prognostic marker in poor outcome endometrial cancer[J].Br J Cancer,2011,104(10):1611-1618.

二级参考文献42

  • 1张维森,江朝强,Lam T.Hing,Ho S.Yin,陈清,刘薇薇,何健民,曹民.接尘、吸烟者死亡危险度比较的前瞻性队列研究[J].中华流行病学杂志,2004,25(9):748-752. 被引量:19
  • 2邹小农.中国肺癌流行病学[J].中华肿瘤防治杂志,2007,14(12):881-883. 被引量:152
  • 3中华人民共和国卫生部.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学生出版社,2008.52-120.
  • 4Piek E, Heldin CH, Ten Dijke P. Specificity, diversity, and regu- lation in TGF-β super family signaling[J].FASEB J, 1999, 13(15) :2105-2124.
  • 5Pasche B. Role of transforming growth factor beta in cancer[J]. J Cell Physiol,2001,186(2) :153-168.
  • 6Luedecking EK, DeKosky ST, Mehdi H, et al. Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer' s disease[J]. Hum Genet, 2000,106 (5) 565-569.
  • 7Silverman ES,Palmer LJ,Subramaniam V, et al. Transforming growth factor-beta1 promoter polymorphism --509C/T is associated with asthma[J]. Am J Respir Crit Care Meal,2004,169(2) : 214-219.
  • 8Wei YS, Zhu YH, Du B, et al. Assiociation of transforming growth factor-β1 gene polymorphisms with genetic susceptibility to nasopha- ryngeal carcinoma[J]. Clin Chim Acta, 2007,380(1-2) : 165-169.
  • 9Jin G, Deng Y, Miao R, et al. TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population [J].J Cancer Res Clin Oncol,2008,13~(3) :345-351.
  • 10Zhang P, Di JZ, Zhu ZZ, et al. Association of transforming growth factor-beta1 poly-morphisms with genetic susceptibility to TNM stage Ⅰ or Ⅱ gastric cancer[J].Jpn J Clin Oncol, 2008,38(1.2) :861- 866.

共引文献21

同被引文献101

引证文献13

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部